• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中风预防:最新进展。

Stroke prevention: an update.

机构信息

Neurology Department, Lariboisière Hospital AP-HP, Paris Diderot University, Paris 75010, France.

出版信息

Front Med. 2012 Mar;6(1):22-34. doi: 10.1007/s11684-012-0178-6. Epub 2012 Mar 31.

DOI:10.1007/s11684-012-0178-6
PMID:22460445
Abstract

Stroke is a personal, familial, and social disaster. It is the third cause of death worldwide, the first cause of acquired disability, the second cause of dementia, and its cost is astronomic. The burden of stroke is likely to increase given the aging of the population and the growing incidence of many vascular risk factors. Prevention of stroke includes--as for all other diseases--a "mass approach" aiming at decreasing the risk at the society level and an individual approach, aiming at reducing the risk in a given subject. The mass approach is primarily based on the identification and treatment of vascular risk factors and, if possible, in the implementation of protective factors. These measures are the basis of primary prevention but most of them have now been shown to be also effective in secondary prevention. The individual approach combines a vascular risk factor modification and various treatments addressing the specific subtypes of stroke, such as antiplatelet drugs for the prevention of cerebral infarction in large and small artery diseases of the brain, carotid endarterectomy or stenting for tight carotid artery stenosis, and oral anticoagulants for the prevention of cardiac emboli. There is a growing awareness of the huge evidence-to-practice gap that exists in stroke prevention largely due to socio-economic factors. Recent approaches include low cost intervention packages to reduce blood pressure and cheap "polypills" combining in a single tablet aspirin and several drugs to lower blood pressure and cholesterol. Polypill intake should however not lead to abandon the healthy life-style measures which remain the mainstay of stroke prevention.

摘要

中风是个人、家庭和社会的灾难。它是全球第三大致死原因,第一大致残原因,第二大致痴呆原因,其费用高得惊人。由于人口老龄化和许多血管危险因素发病率的增加,中风的负担可能会增加。预防中风包括——与所有其他疾病一样——一种旨在降低社会层面风险的“大众方法”,以及一种旨在降低特定个体风险的个体化方法。大众方法主要基于识别和治疗血管危险因素,如果可能的话,还包括实施保护因素。这些措施是一级预防的基础,但大多数措施现在已被证明在二级预防中也有效。个体化方法结合了血管危险因素的改变和针对中风特定亚型的各种治疗方法,例如抗血小板药物预防大脑中动脉和小动脉疾病中的脑梗死,颈动脉内膜切除术或支架置入术治疗颈动脉狭窄,以及口服抗凝剂预防心脏栓塞。人们越来越意识到,由于社会经济因素,中风预防中存在巨大的证据与实践差距。最近的方法包括降低血压的低成本干预方案和廉价的“多效药丸”,将阿司匹林和几种降低血压和胆固醇的药物结合在一片药丸中。然而,多效药丸的摄入不应导致放弃仍然是中风预防主要支柱的健康生活方式措施。

相似文献

1
Stroke prevention: an update.中风预防:最新进展。
Front Med. 2012 Mar;6(1):22-34. doi: 10.1007/s11684-012-0178-6. Epub 2012 Mar 31.
2
Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar.缺血性卒中和脑出血的一级和二级预防:美国心脏病学会焦点研讨会。
J Am Coll Cardiol. 2020 Apr 21;75(15):1804-1818. doi: 10.1016/j.jacc.2019.12.072.
3
Cerebral artery stenosis paves the way for a stroke.脑动脉狭窄为中风埋下隐患。
Nursing. 2006 Jun;36(6):36-41; quiz 41-2. doi: 10.1097/00152193-200606000-00036.
4
Preventable stroke and stroke prevention.
J Thromb Haemost. 2005 Aug;3(8):1638-45. doi: 10.1111/j.1538-7836.2005.01427.x.
5
Prevention. European Stroke Initiative.预防。欧洲卒中倡议组织。
Cerebrovasc Dis. 2004;17 Suppl 2:15-29. doi: 10.1159/000074817.
6
[Stroke prevention].[预防中风]
Ther Umsch. 2003 Sep;60(9):521-6. doi: 10.1024/0040-5930.60.9.521.
7
[Primary prevention of stroke. What helps--what does not help? The guidelines of the German Society of Neurology briefly summarized].[中风的一级预防。哪些有用——哪些没用?德国神经病学学会指南简要总结]
MMW Fortschr Med. 2003;145 Suppl 1:9-10.
8
Place of drug therapy in the treatment of carotid stenosis.药物治疗在颈动脉狭窄治疗中的地位。
CNS Drugs. 2005;19(7):597-622. doi: 10.2165/00023210-200519070-00003.
9
Update on stroke prevention.中风预防的最新进展。
Compr Ther. 2005 Summer;31(2):113-8. doi: 10.1007/s12019-005-0006-x.
10
[Secondary prevention after stroke: healthy life style, oral anticoagulation].[中风后的二级预防:健康生活方式、口服抗凝治疗]
MMW Fortschr Med. 2003 May 26;145 Suppl 2:61-4.

引用本文的文献

1
Rehabilitation in Animal Models of Stroke.中风动物模型的康复
Phys Ther Res. 2023;26(2):39-43. doi: 10.1298/ptr.R0022. Epub 2023 Apr 29.
2
Association of Hepatitis B and C Virus with the Risk of Coronary Artery Disease and Cerebrovascular Disease in Patients with Hepatocellular Carcinoma.乙型和丙型肝炎病毒与肝细胞癌患者冠状动脉疾病和脑血管疾病风险的关联
J Clin Med. 2023 Mar 30;12(7):2602. doi: 10.3390/jcm12072602.
3
Wnt-Dependent Oligodendroglial-Endothelial Interactions Regulate White Matter Vascularization and Attenuate Injury.

本文引用的文献

1
Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review.抑郁与卒中发病率和死亡率风险:一项荟萃分析和系统综述。
JAMA. 2011 Sep 21;306(11):1241-9. doi: 10.1001/jama.2011.1282.
2
Apixaban versus warfarin in patients with atrial fibrillation.阿哌沙班与华法林用于房颤患者。
N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.
3
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.利伐沙班与华法林用于非瓣膜性心房颤动。
Wnt 依赖性少突胶质细胞-血管内皮相互作用调节白质血管生成并减轻损伤。
Neuron. 2020 Dec 23;108(6):1130-1145.e5. doi: 10.1016/j.neuron.2020.09.033. Epub 2020 Oct 20.
4
Characteristics of Cerebral Stroke in the Tibet Autonomous Region of China.中国西藏自治区脑卒中的特征。
Med Sci Monit. 2020 Jan 9;26:e919221. doi: 10.12659/MSM.919221.
5
Classification of Carotid Artery Intima Media Thickness Ultrasound Images with Deep Learning.基于深度学习的颈动脉内中膜超声图像分类。
J Med Syst. 2019 Jul 5;43(8):273. doi: 10.1007/s10916-019-1406-2.
6
Genetic Predisposition to Ischemic Stroke: A Polygenic Risk Score.缺血性中风的遗传易感性:多基因风险评分
Stroke. 2017 Feb;48(2):253-258. doi: 10.1161/STROKEAHA.116.014506. Epub 2016 Dec 29.
7
Increased Risk of Stroke in Patients With Fibromyalgia: A Population-BASED Cohort Study.纤维肌痛患者中风风险增加:一项基于人群的队列研究。
Medicine (Baltimore). 2016 Feb;95(8):e2860. doi: 10.1097/MD.0000000000002860.
8
Determinants of white matter hyperintensity burden differ at the extremes of ages of ischemic stroke onset.缺血性卒中发病年龄两端的白质高信号负荷的决定因素有所不同。
J Stroke Cerebrovasc Dis. 2015 Mar;24(3):649-54. doi: 10.1016/j.jstrokecerebrovasdis.2014.10.016. Epub 2014 Nov 6.
9
Age-dependent exacerbation of white matter stroke outcomes: a role for oxidative damage and inflammatory mediators.年龄依赖性加剧的脑白质卒中结局:氧化损伤和炎症介质的作用。
Stroke. 2013 Sep;44(9):2579-86. doi: 10.1161/STROKEAHA.113.001796. Epub 2013 Jul 18.
10
The immune system in stroke: clinical challenges and their translation to experimental research.中风中的免疫系统:临床挑战及其向实验研究的转化。
J Neuroimmune Pharmacol. 2013 Sep;8(4):867-87. doi: 10.1007/s11481-013-9469-1. Epub 2013 May 15.
N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.
4
Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials.人群叶酸对 MTHFR 基因型、同型半胱氨酸与卒中风险之间关联的修饰作用:基于遗传研究和随机试验的荟萃分析。
Lancet. 2011 Aug 13;378(9791):584-94. doi: 10.1016/S0140-6736(11)60872-6. Epub 2011 Jul 29.
5
Reduced dietary salt for the prevention of cardiovascular disease.减少膳食盐摄入以预防心血管疾病。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD009217. doi: 10.1002/14651858.CD009217.
6
Global variation in the relative burden of stroke and ischemic heart disease.全球范围内卒中与缺血性心脏病的相对负担变化。
Circulation. 2011 Jul 19;124(3):314-23. doi: 10.1161/CIRCULATIONAHA.111.018820. Epub 2011 Jul 5.
7
Reducing the global burden of ischemic heart disease and stroke: a challenge for the cardiovascular community and the United Nations.减轻全球缺血性心脏病和中风负担:心血管领域及联合国面临的一项挑战。
Circulation. 2011 Jul 19;124(3):278-9. doi: 10.1161/CIRCULATIONAHA.111.040170. Epub 2011 Jul 5.
8
What is the current status of invasive treatment of extracranial carotid artery disease?颅外颈动脉疾病的介入治疗现状如何?
Stroke. 2011 Jul;42(7):2080-5. doi: 10.1161/STROKEAHA.110.597708. Epub 2011 Jun 9.
9
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.特鲁沙班与阿司匹林治疗脑缺血事件的疗效比较(PERFORM):一项随机、双盲、平行分组试验。
Lancet. 2011 Jun 11;377(9782):2013-22. doi: 10.1016/S0140-6736(11)60600-4. Epub 2011 May 25.
10
Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke.短暂性脑缺血发作和缺血性脑卒中后的急性和长期二级预防中的医疗处理。
Lancet. 2011 May 14;377(9778):1681-92. doi: 10.1016/S0140-6736(11)60516-3.